{"id":"https://openalex.org/W2805631143","doi":"https://doi.org/10.1111/bcp.13668","title":"A first\u2010in\u2010man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM\u20101 receptor inhibition","display_name":"A first\u2010in\u2010man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM\u20101 receptor inhibition","publication_year":2018,"publication_date":"2018-06-09","ids":{"openalex":"https://openalex.org/W2805631143","doi":"https://doi.org/10.1111/bcp.13668","mag":"2805631143","pmid":"https://pubmed.ncbi.nlm.nih.gov/29885068","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6138490"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.13668","doi":"https://doi.org/10.1111/bcp.13668","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.13668","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6138490/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077637262","display_name":"Val\u00e9rie Cuvier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271659","display_name":"Inotrem (France)","ror":"https://ror.org/02t4pph48","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405271659"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Valerie Cuvier","raw_affiliation_strings":["Inotrem, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotrem, Paris, France","institution_ids":["https://openalex.org/I4405271659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082211920","display_name":"Ulrike Lorch","orcid":"https://orcid.org/0000-0002-6316-5860","observed_orcids":["https://orcid.org/0000-0002-6316-5860"]},"institutions":[{"id":"https://openalex.org/I165862685","display_name":"St George's, University of London","ror":"https://ror.org/040f08y74","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I165862685","https://openalex.org/I4401726869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ulrike Lorch","raw_affiliation_strings":["Richmond Pharmacology, St George's University of London, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-6316-5860","affiliations":[{"raw_affiliation_string":"Richmond Pharmacology, St George's University of London, London, UK","institution_ids":["https://openalex.org/I165862685"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Stephan Witte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271659","display_name":"Inotrem (France)","ror":"https://ror.org/02t4pph48","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405271659"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stephan Witte","raw_affiliation_strings":["Inotrem, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotrem, Paris, France","institution_ids":["https://openalex.org/I4405271659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041708573","display_name":"Aur\u00e9lie Olivier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271659","display_name":"Inotrem (France)","ror":"https://ror.org/02t4pph48","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405271659"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aurelie Olivier","raw_affiliation_strings":["Inotrem, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotrem, Paris, France","institution_ids":["https://openalex.org/I4405271659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039023548","display_name":"S\u00e9bastien Gibot","orcid":"https://orcid.org/0000-0001-6067-4662","observed_orcids":["https://orcid.org/0000-0001-6067-4662"]},"institutions":[{"id":"https://openalex.org/I4210100260","display_name":"Centre Hospitalier R\u00e9gional et Universitaire de Nancy","ror":"https://ror.org/016ncsr12","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100260"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sebastien Gibot","raw_affiliation_strings":["ICU Hospital Central, Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICU Hospital Central, Nancy, France","institution_ids":["https://openalex.org/I4210100260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035517886","display_name":"Isabelle Delor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabelle Delor","raw_affiliation_strings":["MnS Modeling and Simulation, Dinant, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MnS Modeling and Simulation, Dinant, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046584400","display_name":"Jean\u2013Jacques Garaud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271659","display_name":"Inotrem (France)","ror":"https://ror.org/02t4pph48","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405271659"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean\u2010Jacques Garaud","raw_affiliation_strings":["Inotrem, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotrem, Paris, France","institution_ids":["https://openalex.org/I4405271659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041089831","display_name":"Marc Derive","orcid":"https://orcid.org/0000-0002-8707-5923","observed_orcids":["https://orcid.org/0000-0002-8707-5923"]},"institutions":[{"id":"https://openalex.org/I4405271659","display_name":"Inotrem (France)","ror":"https://ror.org/02t4pph48","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405271659"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marc Derive","raw_affiliation_strings":["Inotrem, Paris, France"],"raw_orcid":"https://orcid.org/0000-0002-8707-5923","affiliations":[{"raw_affiliation_string":"Inotrem, Paris, France","institution_ids":["https://openalex.org/I4405271659"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083844303","display_name":"Margarita Salcedo\u2010Magguilli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271659","display_name":"Inotrem (France)","ror":"https://ror.org/02t4pph48","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405271659"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Margarita Salcedo\u2010Magguilli","raw_affiliation_strings":["Inotrem, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotrem, Paris, France","institution_ids":["https://openalex.org/I4405271659"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5083844303"],"corresponding_institution_ids":["https://openalex.org/I4405271659"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.7642,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.8383553,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"84","issue":"10","first_page":"2270","last_page":"2279"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14165","display_name":"Inflammation biomarkers and pathways","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T14165","display_name":"Inflammation biomarkers and pathways","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trem-1","display_name":"TREM-1","score":0.9340000152587891},{"id":"https://openalex.org/keywords/septic-shock","display_name":"septic shock","score":0.7699999809265137},{"id":"https://openalex.org/keywords/acute-inflammation","display_name":"acute inflammation","score":0.6290000081062317},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8320000171661377},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8659999966621399},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.75},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.9229999780654907},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.6890000104904175}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8079687356948853},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8012274503707886},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6575785875320435},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6060442924499512},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5960708856582642},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5950044989585876},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5319481492042542},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4262315630912781},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35214871168136597},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33832603693008423},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09380558133125305},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000073871","descriptor_name":"Triggering Receptor Expressed on Myeloid Cells-1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007113","descriptor_name":"Immunity, Innate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bcp.13668","doi":"https://doi.org/10.1111/bcp.13668","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.13668","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:29885068","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29885068","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:6138490","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6138490/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:6138490","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6138490/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2251049304","display_name":null,"funder_award_id":"ANR-15-RHU-0004","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"},{"id":"https://openalex.org/G6622507228","display_name":"Combattre l'insuffisance cardiaque","funder_award_id":"ANR-15-RHUS-0004","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"}],"funders":[{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W167457516","https://openalex.org/W1479710986","https://openalex.org/W1538575359","https://openalex.org/W1565780015","https://openalex.org/W1643888758","https://openalex.org/W1965987183","https://openalex.org/W1967295501","https://openalex.org/W1989246885","https://openalex.org/W1997720276","https://openalex.org/W2012325198","https://openalex.org/W2023091390","https://openalex.org/W2032731674","https://openalex.org/W2033028058","https://openalex.org/W2036514375","https://openalex.org/W2043930928","https://openalex.org/W2047796994","https://openalex.org/W2051731334","https://openalex.org/W2058682780","https://openalex.org/W2066332911","https://openalex.org/W2077408745","https://openalex.org/W2080678175","https://openalex.org/W2086080938","https://openalex.org/W2091092330","https://openalex.org/W2092035190","https://openalex.org/W2097364950","https://openalex.org/W2113212360","https://openalex.org/W2113348908","https://openalex.org/W2128413447","https://openalex.org/W2132714993","https://openalex.org/W2134128095","https://openalex.org/W2137082708","https://openalex.org/W2145736817","https://openalex.org/W2145889332","https://openalex.org/W2149698238","https://openalex.org/W2150747928","https://openalex.org/W2155533398","https://openalex.org/W2158427654","https://openalex.org/W2167072390","https://openalex.org/W2171859462","https://openalex.org/W2335233413","https://openalex.org/W2375772230","https://openalex.org/W2530318795","https://openalex.org/W2560162242","https://openalex.org/W2581773567","https://openalex.org/W2612459567"],"related_works":["https://openalex.org/W4410494807","https://openalex.org/W4409734281","https://openalex.org/W4400014003","https://openalex.org/W2771915289","https://openalex.org/W2979752476","https://openalex.org/W4391444453","https://openalex.org/W4407592806","https://openalex.org/W4311146587","https://openalex.org/W3089045575","https://openalex.org/W3045420509"],"abstract_inverted_index":{"Aims":[0],"The":[1,74,233],"peptide":[2],"nangibotide":[3,236],"is":[4,20],"the":[5,10,46,140,212],"first":[6,75],"clinical\u2010stage":[7],"agent":[8],"targeting":[9],"immunoreceptor":[11],"TREM\u20101":[12],"(triggering":[13],"receptor":[14],"expressed":[15],"on":[16],"myeloid":[17],"cells\u20101)":[18],"and":[19,49,85,135,150,156,180,196,204,217,240,251],"being":[21],"investigated":[22],"as":[23,32,68],"a":[24,69,79,97,121,167,175,181],"novel":[25,234],"therapy":[26],"for":[27,174],"acute":[28],"inflammatory":[29],"disorders":[30],"such":[31],"septic":[33],"shock.":[34],"This":[35],"first\u2010in\u2010man,":[36],"randomized,":[37],"double\u2010blind,":[38],"ascending":[39],"dose,":[40],"placebo\u2010controlled":[41],"Phase":[42],"I":[43],"study":[44],"evaluated":[45],"safety,":[47],"tolerability":[48],"pharmacokinetics":[50],"of":[51,83,102,125,169,177,199,211],"nangibotide.":[52],"Methods":[53],"Twenty\u2010seven":[54],"healthy":[55],"subjects":[56],"(aged":[57],"18\u201345":[58],"years)":[59],"were":[60,94,145,152,201,224],"randomized":[61,95],"into":[62],"eight":[63],"groups.":[64],"Nangibotide":[65,132,161],"was":[66,133],"administered":[67],"single":[70,80],"continuous":[71],"intravenous":[72],"infusion.":[73],"two":[76],"groups":[77,93],"received":[78],"i.v.":[81],"dose":[82,124,142],"1":[84],"10":[86],"mg,":[87],"respectively,":[88,207],"over":[89,114],"15":[90],"min.":[91],"Subsequent":[92],"in":[96,154,193,215],"product":[98],":":[99],"placebo":[100],"ratio":[101],"3:1":[103],"at":[104,243],"doses":[105],"ranging":[106],"from":[107],"0.03":[108],"to":[109,127,139,159,227],"6":[110],"mg":[111,129],"kg\u22121":[112,172],"h\u22121":[113,173],"7":[115],"h":[116],"45":[117],"min,":[118],"preceded":[119],"by":[120],"15\u2010minute":[122],"loading":[123],"up":[126,138,226],"5":[128],"kg\u22121.":[130],"Results":[131],"safe":[134],"well":[136],"tolerated":[137],"highest":[141],"tested.":[143],"There":[144],"only":[146],"few":[147],"adverse":[148],"events":[149],"they":[151],"mild":[153],"severity":[155],"considered":[157],"unrelated":[158],"treatment.":[160],"displayed":[162,237],"dose\u2010proportional":[163],"PK":[164,241],"properties,":[165],"with":[166,189],"clearance":[168],"6.6":[170],"l":[171,203,206],"subject":[176],"70":[178],"kg":[179],"3":[182],"min":[183],"effective":[184],"half\u2010life,":[185],"which":[186],"are":[187],"compatible":[188],"extensive":[190],"enzymatic":[191],"metabolism":[192],"blood.":[194],"Central":[195],"peripheral":[197],"volumes":[198],"distribution":[200,210],"16.7":[202],"15.9":[205],"indicating":[208],"limited":[209],"drug":[213],"mainly":[214],"blood":[216],"interstitial":[218],"fluid.":[219],"No":[220],"circulating":[221],"anti\u2010drug":[222],"antibodies":[223],"detectable":[225],"28":[228],"days":[229],"after":[230],"administration.":[231],"Conclusions":[232],"immunomodulator":[235],"favourable":[238],"safety":[239],"profiles":[242],"all":[244],"doses,":[245,250],"including":[246],"expected":[247],"pharmacologically":[248],"active":[249],"warrants":[252],"further":[253],"clinical":[254],"development.":[255]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-06-13T00:00:00"}